https://insights.omicsx.com/oncology-clinical-stage-kinase-inhibitors/
Kinase Inhibitors in Clinical Development - 2021 - Drug Development Insights by OmicsX
May 30, 2022 - First cancer targeting tyrosine kinase inhibitor imatinib was approved to enter the market by the US Food and Drug Administration
clinical developmentkinaseinhibitorsdruginsights
https://omicsx.com/decision/
Decision Operating System - OmicsX | Decision Operating Systems for Drug Discovery
May 10, 2026 - MOST PROGRAMS FAIL before they are supposed to Invisible failures. Early Decisions. Uncontrolled variables. Unresolved biology is treated as progress...
operating systemdecisionsystemsdrugdiscovery